USA flag logo/image

An Official Website of the United States Government

MAGNETICALLY ENERGIZED NANOPARTICLES FOR TREATING OVARIAN CANC

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
96158
Program Year/Program:
2010 / SBIR
Agency Tracking Number:
N43CO201000069
Solicitation Year:
N/A
Solicitation Topic Code:
NCI
Solicitation Number:
N/A
Small Business Information
ASPEN MEDISYS, LLC
184 CEDAR HILL ST MARLBOROUGH, MA 01752-
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 2010
Title: MAGNETICALLY ENERGIZED NANOPARTICLES FOR TREATING OVARIAN CANC
Agency: HHS
Contract: N43CO201000069
Award Amount: $200,000.00
 

Abstract:

Certain magnetic nanoparticles produce substantial heat under high strength alternating magnetic fields. These particles will be introduced into the body such that they accumulate in cancerous tissues. Ovarian cancer is characterized by an abundance of immunosuppressive phagocytes. Nanoparticles are ideal agents for the purpose of targeting these phagocytes, rationalized as follows. First, even when metastatic, ovarian cancer is most frequently restricted to the peritoneal cavity. Nanoparticles are readily injected into the tumor-associated-phagocyte-rich ascitic fluid that irrigates multiple peritoneal tumor masses. Second , these abundant natural phagocytes are the target of our therapy. In the treatment of other metastatic diseases, nanoparticle uptake after intravenous injection by cells of the reticuloendothelial system limits tumor exposure and is an impediment to delivery of systemically administered nanoparticles. Here, the phagocytes are our target. Third, after nanoparticle uptake these phagocytes act as delivery vehicles , migrating into tumor masses where they may better exert a therapeutic effect treatment. Fourth, nanoparticle activation can transform these immunosupressive phagocytes into immunostimulating phenotype. Ovarian cancer is a disease that is often discovered at an advanced stage and is poorly served by current treatment options. Our approach is designed to engage and better enable the patients immune system to fight the disease.

Principal Investigator:

Stephen Barry
(508) 380-7048
Small Business Information at Submission:

ASPEN MEDISYS, LLC
184 CEDAR HILL ST MARLBOROUGH, MA 01752-

EIN/Tax ID: 000000000
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No